Therefore, a better understanding of their mechanism of action through the key signaling pathways and metabolic pathways in which they participate is essential for developing Treg cell-based ...

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Beginning in late 2023, CASGEVY ® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR ...

This pharmacodynamic measurement is based on the analysis of specific biomarkers strongly related with the mechanism of action of every immunosuppressive agent, and shows its immunomodulatory ...

Two mechanisms are responsible for iron overload in β-thalassemia: increased iron absorption due to ineffective erythropoiesis and blood transfusions. This review examines the mechanisms of myocardial ...

Cameron Diaz is officially Back in Action! The Bad Teacher beauty, 52, hasn’t been seen in a movie since 2014’s Annie — so naturally, her return to movies is newsworthy. The blonde bombshell ...

Inc.'s ("Editas") payment rights under a non-exclusive license to Vertex Pharmaceuticals Incorporated ("Vertex") of Editas Medicine's Cas9 gene-editing technology for CASGEVY® (exagamglogene ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Award celebrates Dr. High's foundational work in the gene therapy space, from her pioneering clinical work with AAVs to her entrepreneurial leadership in the development of multiple commercial ...